The future of the RTS,S/AS01 malaria vaccine: an alternative development plan

The future of the RTS,S/AS01 malaria vaccine: an alternative development plan

RTS,S/AS01 is the falciparum malaria vaccine candidate that is most advanced in development, globally.<br/> In a large clinical trial in sub-Saharan African children, the protection conferred by RTS,S/AS01 was found to rapidly decline, particularly in infants. <br/>Although RTS,S/AS01 wa...

Detaylı Bibliyografya
Asıl Yazarlar:	Gosling, R, von Seidlein, L
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Public Library of Science 2015

Benzer Materyaller

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.
Yazar:: Roly Gosling, ve diğerleri
Baskı/Yayın Bilgisi: (2016-04-01)

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
Yazar:: Bejon, P, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan
Yazar:: Shima Mahmoudi, ve diğerleri
Baskı/Yayın Bilgisi: (2017-09-01)

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
Yazar:: Juliette Fortpied, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

RTS,S/AS01 malaria vaccine in African children.
Yazar:: Hill, A
Baskı/Yayın Bilgisi: (2012)

THE RTS,S MALARIA VACCINE What is the efficacy of the RTS,S malaria vaccine?
Yazar:: Duncan, C, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
Yazar:: Hassan Mumtaz, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
Yazar:: Griffin J. Bell, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

RTS,S/AS01 vaccine (Mosquirix™): an overview
Yazar:: Matthew B. Laurens
Baskı/Yayın Bilgisi: (2020-03-01)

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
Yazar:: Olotu, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
Yazar:: Agnandji, S, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
Yazar:: Aroosa Younis Nadeem, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Acceptance, availability and feasibility of RTS, S/AS01 malaria vaccine: A review of literature
Yazar:: Abdullah Nadeem, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Simulated impact of RTS,S/AS01 vaccination programs in the context of changing malaria transmission.
Yazar:: Alan Brooks, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
Yazar:: Arora N, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
Yazar:: Bejon, P, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
Yazar:: Lusingu, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report
Yazar:: Corinne S. Merle, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

RTS,S: the first malaria vaccine
Yazar:: Fidel Zavala
Baskı/Yayın Bilgisi: (2022-01-01)

Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa
Yazar:: Galactionova, K, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
Yazar:: Agnandji, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
Yazar:: Mark E Polhemus, ve diğerleri
Baskı/Yayın Bilgisi: (2009-07-01)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
Yazar:: John N Waitumbi, ve diğerleri
Baskı/Yayın Bilgisi: (2009-11-01)

Correction: Randomized Controlled Trial of RTS,S/AS02 and RTS,S/AS01 Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children.
Yazar:: Seth Owusu-Agyei, ve diğerleri
Baskı/Yayın Bilgisi: (2010-01-01)

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
Yazar:: Daniel Ansong, ve diğerleri
Baskı/Yayın Bilgisi: (2011-04-01)

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.
Yazar:: Horowitz, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
Yazar:: John Lusingu, ve diğerleri
Baskı/Yayın Bilgisi: (2010-01-01)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
Yazar:: John Lusingu, ve diğerleri
Baskı/Yayın Bilgisi: (2010-11-01)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
Yazar:: John Lusingu, ve diğerleri
Baskı/Yayın Bilgisi: (2010-01-01)

The clinical profile of severe paediatric malaria in an area targeted for routine RTS,S/AS01 malaria vaccination in Western Kenya
Yazar:: Akech, S, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
Yazar:: Bejon, P, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Seasonal targeting of the RTS,S/AS01 malaria vaccine: a complementary tool but sustained funding is required
Yazar:: Silal, SP
Baskı/Yayın Bilgisi: (2023)

Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status
Yazar:: Stephaney Gyaase, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.
Yazar:: Seth Owusu-Agyei, ve diğerleri
Baskı/Yayın Bilgisi: (2009-10-01)

The future of malaria control in light of RTS,S
Yazar:: Priya Venkatesan
Baskı/Yayın Bilgisi: (2022-04-01)

What is the efficacy of the RTS,S malaria vaccine?
Yazar:: Duncan, C, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

What is the efficacy of the RTS,S malaria vaccine?
Yazar:: Duncan, C, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01 E
Yazar:: Ali, MS, ve diğerleri
Baskı/Yayın Bilgisi: (2025)

Correction: Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
Baskı/Yayın Bilgisi: (2010-01-01)

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
Yazar:: Olotu, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)